Increasing Amount of Breast Cancer-Specific Death Due to Stage 1, 2 Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 10, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Oct. 10, 2024 -- Patients with stage I/II breast cancers have excellent prognosis, but account for more than 60 percent of breast cancer-specific death (BCSD) because of their large absolute volumes, according to a study published online Sept. 30 in the Journal of the National Cancer Institute.

Michal Marczyk, Ph.D., from Silesian University of Technology in Gliwice, Poland, and colleagues used the Surveillance, Epidemiology, and End Results database (1975 to 2017) to identify 972,763 patients who were female sex at birth and had one primary tumor type, surgery, American Joint Committee on Cancer (6th edition) stage >0, no bilateral cancer, and available survival data. Trends in the fractions of annual BCSD due to stage I, II, III, and IV disease were examined.

The researchers found that the contribution of stage I and II cancers to BCSD increased significantly from 16.2 to 23.1 percent and from 30.7 to 39.5 percent, respectively, between 2000 and 2017. During the same period, the contribution of stages III and IV cancers decreased from 36.4 to 30.3 percent and from 16.7 to 7.1 percent, respectively. BCSD due to T1a, T1b, and T1c node-negative cancers in 2000 were 0.92, 4.0, and 10.7 percent, respectively, which increased significantly to 1.9, 5.8, and 14.7 percent, respectively, by 2017. Similar temporal trends were seen for hormone receptor-positive and negative cancers. For all-cause mortality, the contribution of BCSD declined from 23.9 to 16.6 percent for stage I cancers and from 47.7 to 36.9 percent for stage II cancers by 2017.

"To further reduce breast cancer death, strategies are needed to identify and treat patients with stage I/II disease who remain at risk for recurrence," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-11 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords